Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non‐small‐cell lung cancer

Ähnliche Einträge

• Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non‐small‐cell lung cancer
  von: Yu Wang, et al.
  Veröffentlicht: (2025)
• Back Cover: Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non‐small‐cell lung cancer (View 3/2025)
  von: Yu Wang, et al.
  Veröffentlicht: (2025)
• Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
  von: Li Li, et al.
  Veröffentlicht: (2024)
• Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer
  von: Jie Tang, et al.
  Veröffentlicht: (2024)
• The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer
  von: Guangyu Fan, et al.
  Veröffentlicht: (2024)